BiotechCorp Annual Report 2007 - Malaysian Biotechnology ...

More documents

Recommendations

Info

56 Malaysian Biotechnology Corporation Sdn. Bhd. (Company No.691431-D) (Incorporated in Malaysia) Statutory declaration pursuant to Section 169(16) of the Companies Act, 1965 I, Raja Ridzwa Bin Raja Abdul Aziz, the officer primarily responsible for the financial management of Malaysian Biotechnology Corporation Sdn. Bhd., do solemnly and sincerely declare that the financial statements set out on pages 58 to 76 are, to the best of my knowledge and belief, correct and I make this solemn declaration conscientiously believing the same to be true, and by virtue of the provisions of the Statutory Declarations Act, 1960. Subscribed and solemnly declared by the above named in Kuala Lumpur on ................................................................. .….…………………………………….. Raja Ridzwa Bin Raja Abdul Aziz Before me:
Report of the auditors to the members of Malaysian Biotechnology Corporation Sdn. Bhd. (Company No.691431-D) (Incorporated in Malaysia) We have audited the financial statements set out on pages 58 to 76. The preparation of the financial statements is the responsibility of the Company’s Directors. It is our responsibility to form an independent opinion, based on our audit, on the financial statements and to report our opinion to you, as a body, in accordance with Section 174 of the Companies Act, 1965 and for no other purpose. We do not assume responsibility to any other person for the content of this report. We conducted our audit in accordance with the approved Standards on Auditing in Malaysia. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by the Directors, as well as evaluating the overall financial statements presentation. We believe our audit provides a reasonable basis for our opinion. In our opinion: (a) the financial statements are properly drawn up in accordance with the provisions of the Companies Act, 1965 and applicable approved accounting standards for private entities issued by the Malaysian Accounting Standards Board so as to give a true and fair view of: i) the state of affairs of the Company at 31 December 2007 and of the results and cash flows for the year ended on that date; and ii) the matters required by Section 169 of the Companies Act, 1965 to be dealt with in the financial statements of the Company; and (b) the accounting and other records and the registers required by the Companies Act, 1965 to be kept by the Company have been properly kept in accordance with the provisions of the said Act. KPMG Desa Megat & Co. Abdullah Abu Samah Firm Number: AF 0759 Partner Chartered Accountants Approval Number: 2013/06/08(J) Kuala Lumpur, Date: 57
Page 1 and 2:
BI TECH BEGINS BiotechCorp Annual R
Page 3 and 4:
Industry Overview Facts & Figures 3
Page 5 and 6:
Facts & Figures Malaysia’s compet
Page 7 and 8: The National Biotechnology Policy T
Page 9 and 10: Wealth Creation and Societal Wellbe
Page 11 and 12: Chairman’s Message YBhg Tan Sri D
Page 13 and 14: Number of BioNexus Companies by Sta
Page 15 and 16: Corporate Information • Registere
Page 17 and 18: 3. YBhg Tan Sri Datuk Dr Haji Moham
Page 19 and 20: 7. Puan Zaiton Jamaluddin Puan Zait
Page 22 and 23: 20 CEO's Office Monitoring & Compli
Page 24 and 25: 22 Biotechnology Begins
Page 26 and 27: 24 BiotechCorp also acts as a one-s
Page 28 and 29: 26 2005 • Launch of the National
Page 30 and 31: 28 Overview of Achievements
Page 32 and 33: 30 30 List of BioNexus Companies as
Page 34 and 35: 32 Mentoring Programmes BiotechCorp
Page 36 and 37: 34 Acquisition of new technology pl
Page 38 and 39: 36 Moving Forward
Page 40 and 41: 38 Potential Technology Platforms f
Page 42 and 43: 40 The Statement o n C o r p o r a
Page 44 and 45: 42 During the financial year ended
Page 46 and 47: 44 Membership composition of the si
Page 48 and 49: 46 (v) CWG on Funding Support Chair
Page 50 and 51: 48 Organisation and Management Stru
Page 52 and 53: 50 The Financial Statements
Page 54 and 55: 52 Malaysian Biotechnology Corporat
Page 56 and 57: 54 (Company No.691431-D) iii) which
Page 64 and 65: 62 (Company No.691431-D) Cash flow
Page 66 and 67: 64 (Company No.691431-D) 1. Signifi
Page 68 and 69: 66 (Company No.691431-D) 1. Signifi
Page 70 and 71: 68 (Company No.691431-D) 2. Propert
Page 72 and 73: 70 (Company No.691431-D) 6. Other p
Page 74 and 75: 72 (Company No.691431-D) 9. Deferre
Page 76 and 77: 74 13. Tax expense Reconcilation of
Page 78: 76 (Company No.691431-D) 16. Financ
show all

BiotechCorp Annual Report 2007 - Malaysian Biotechnology ...

Create successful ePaper yourself

Delete template?

Save as template?